Cipla wants 'off-monopoly' HIV drug trade-off in Indian air levy talks
This article was originally published in Scrip
Executive Summary
Cipla, the world's largest single supplier of HIV drugs in terms of volume, has rebuked a call by the international funding organisation UNITAID for a small air ticket levy in India to help finance the purchase of cut-price drugs for HIV/AIDS, malaria and tuberculosis.